Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 100 publications.

Knox B, Guil-Oumrait N, Basagana X, Cserbik D, Dadvand P, Foraster M, Galmes T, Gascon M, Dolores Gomez-Roig M, Gomez-Herrera L, Smastuen Haug L, Llurba E, Marquez S, Rivas I, Sunyer J, Thomsen C, Julia Zanini M, Bustamante M, Vrijheid M. Prenatal exposure to per- and polyfluoroalkyl substances, fetoplacental hemodynamics, and fetal growth. Environ Int. 2024 Nov;193:109090. doi: 10.1016/j.envint.2024.109090

Cadman T, Strandberg-Larsen K, Calas L, Christiansen M, Culpin I, Dadvand P, de Castro M, Foraster M, Fossati S, Guxens M, Harris JR, Hillegers M, Jaddoe V, Lee Y, Lepeule J, El Marroun H, Maule M, McEachen R, Moccia C, Nader J, Nieuwenhuijsen M, Nybo Andersen AM, Pearson R, Swertz M, Vafeiadi M, Vrijheid M, Wright J, Lawlor DA, Pedersen M. Urban environment in pregnancy and postpartum depression: an individual participant data meta-analysis of 12 European birth cohorts. Environ Int. 2024 Mar;185:108453. doi: 10.1016/j.envint.2024.108453

Perez-Crespo L, Lopez-Vicente M, Valentin A, Burgaleta M, Foraster M, Tiemeier H, Guxens M. Association between residential exposure to road traffic noise and cognitive and motor function outcomes in children and preadolescents. Environ Int. 2024 Jan;183:108414. doi: 10.1016/j.envint.2023.108414

Curtis R, Decker-Palmer M, Wilson MR, McDade CL, Lin CW, Wallick C, Ko RH. Cost-effectiveness of emicizumab vs efanesoctocog alfa, standard half life (SHL) and other extended half life (EHL) FVIII products for prophylaxis in people with severe hemophilia a without inhibitors. Poster presented at the 65th ASH Annual Meeting & Exposition 2023; December 11, 2023. San Diego, CA. [abstract] Blood. 2023 Nov; 142(Supplement 1):5053-4. doi: 10.1182/blood-2023-181062

Dorling P, Luzzi R, McMichael A, Kent C, Canty E, Myers K, Badawy SM. Patients' preferences for dosing frequency and out-of-pocket cost associated with iron chelators: a mixed-methods pilot study in the United States. Poster presented at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition; December 7, 2023. San Diego, CA. [abstract] Blood. 2023 Nov; 142(Suppl 1):7203. doi: 10.1182/blood-2023-186416

Wesselink AK, Hystad P, Kirwa K, Kaufman JD, Willis MD, Wang TR, Szpiro AA, Levy JI, Savitz DA, Rothman KJ, Hatch EE, Wise LA. Air pollution and fecundability in a North American preconception cohort study. Environ Int. 2023 Nov;181:108249. doi: 10.1016/j.envint.2023.108249

Torres Toda M, Avraam D, James Cadman T, Fossati S, de Castro M, Dedele A, Donovan G, Elhakeem A, Estarlich M, Fernandes A, Goncalves R, Grazuleviciene R, Harris JR, Harskamp-van Ginkel MW, Heude B, Ibarluzea J, Iniguez C, Wv Jaddoe V, Lawlor D, Lertxundi A, Lepeule J, McEachan R, Moirano G, Nader JL, Nybo Andersen AM, Pedersen M, Pizzi C, Roumeliotaki T, Santos S, Sunyer J, Yang T, Vafeiadi M, Vrijkotte TG, Nieuwenjuijsen M, Vrijheid M, Foraster M, Dadvand P. Exposure to natural environments during pregnancy and birth outcomes in 11 European birth cohorts. Environ Int. 2022 Dec;170:107648. doi: 10.1016/j.envint.2022.107648

Srivastava A, Rangarajan S, Ross C, Slota C, DiBenedetti D, Cano V, Andersson S, DasMahapatra P, Bartelt-Hofer J, Afonso M. Fitusiran reaches people's with hemophilia and their caregivers' treatment expectations: qualitative semi-structured interviews of participants of ATLAS-OLE Trial (Interim analysis). Poster presented at the American Society of Hematology (ASH) Annual Meeting 2022; December 11, 2022. New Orleans, LA. [abstract] Blood. 2022 Nov 15; 140(Suppl 1):7989-90. doi: 10.1182/blood-2022-166895

Messina AJ, Byrd R, McDonough K, Flora DR, Schneider S, Towne SD, Prock J, Donald L, Platt D, Bentley JK. Understanding the patient experience of those who have undergone or considered CAR T-cell therapy in the United States: CAR T-cell therapy Patient Engagement Project (CPEP). Poster presented at the 64th American Society of Hematology (ASH) Annual Meeting; December 10, 2022. New Orleans, LA. [abstract] Blood. 2022 Nov 15; 140(Suppl 1):5246-7. doi: 10.1182/blood-2022-159836

Perez-Crespo L, Kusters MSW, Lopez-Vicente M, Lubczynska MJ, Foraster M, White T, Hoek G, Tiemeier H, Muetzel RL, Guxens M. Exposure to traffic-related air pollution and noise during pregnancy and childhood, and functional brain connectivity in preadolescents. Environ Int. 2022 Jun;164:107275. doi: 10.1016/j.envint.2022.107275

Khomenko S, Cirach M, Barrera-Gomez J, Pereira-Barboza E, Lungman T, Mueller N, Foraster M, Tonne C, Thondoo M, Jephcote C, Gulliver J, Woodcock J, Nieuwenjuijsen M. Impact of road traffic noise on annoyance and preventable mortality in European cities: a health impact assessment. Environ Int. 2022 Apr;162:107160. doi: 10.1016/j.envint.2022.107160

Abellan A, Mensink-Bout SM, Garcia-Esteban R, Beneito A, Chatzi L, Duarte-Salles T, Fernandez MF, Garcia-Aymerich J, Granum B, Iniguez C, Jaddoe VWV, Kannan K, Lertxundi A, Lopez-Espinosa MJ, Philippat C, Sakhi AK, Santos S, Siroux V, Sunyer J, Trasande L, Vafeiadi M, Vela-Soria F, Yang TC, Zabaleta C, Vrijheid M, Duijts L, Casas M. In utero exposure to bisphenols and asthma, wheeze, and lung function in school-age children: a prospective meta-analysis of 8 European birth cohorts. Environ Int. 2022 Apr;162:107178. doi: 10.1016/j.envint.2022.107178

Essers E, Perez-Crespo L, Foraster M, Ambros A, Tiemeier H, Guxens M. Environmental noise exposure and emotional, aggressive, and attention-deficit/hyperactivity disorder-related symptoms in children from two European birth cohorts. Environ Int. 2022 Jan;158:106946. doi: 10.1016/j.envint.2021.106946

Joly F, DasMahapatra P, Su J, DiBenedetti D, Kosa K, Hill Q. Development of a cold Agglutinin disease-specific patient-reported outcome symptom measure. Poster presented at the 2021 63rd American Society of Hematology (ASH) Annual Meeting & Exposition; December 13, 2021. [abstract] Blood. 2021 Nov 23; 138(supplement 1):4057. doi: 10.1182/blood-2021-147199

Walters MC, Tisdale JF, Mapara MY, Krishnamurti L, Kwiatkowski JL, Aygun B, Kasow KA, Rifkin-Zenenberg S, Jaroscak J, Garbinsky D, Chirila C, Gallagher ME, Zhang X, Ho PR, Thompson AA, Kanter J. Sustained improvements in patient-reported quality of life up to 24 months post-treatment with LentiGlobin for sickle cell disease (bb1111) gene therapy. Presented at the 2021 63rd American Society of Hematology (ASH) Annual Meeting & Exposition; December 11, 2021. Atlanta, Georgia. [abstract] Blood. 2021 Nov 23; 138(Suppl 1):7. doi: 10.1182/blood-2021-146905

Germing U, Goyal RK, Yucel A, Parikh RC, Jimenez M, Sluga-O'Callaghan M, Tang D, Hughes C, Diez-Campelo M. Real-world evidence on treatment utilization in lower-risk myelodysplastic syndromes: findings from a medical record review in the United States. Poster presented at the 63rd ASH Annual Meeting and Exposition; December 11, 2021. Atlanta, GA. [abstract] Blood. 2021 Nov 23; 138(Suppl 1):4666. doi: 10.1182/blood-2021-145576

Gignac F, Barrera-Gomez J, Persavento C, Sole C, Tena E, Lopez-Vicente M, Foraster M, Amato F, Alastuey A, Querol X, Llavador H, Apesteguia J, Julvez J, Couso D, Sunyer J, Basagana X. Short-term effect of air pollution on attention function in adolescents (ATENC!Ó): a randomized controlled trial in high schools in Barcelona, Spain. Environ Int. 2021 Nov;156:106614. doi: 10.1016/j.envint.2021.106614

Guil-Oumrait N, Valvi D, Garcia-Esteban R, Guxens M, Sunyer J, Torrent M, Casas M, Vrijheid M. Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescents. Environ Int. 2021 Jun;151:106469. doi: 10.1016/j.envint.2021.106469

Anderson S, Talbird S, Fishman J. Cost per responder analysis for pegcetacoplan and eculizumab in the treatment of adults with paroxysmal nocturnal hemoglobinuria. Blood. 2021;138(Suppl 1):4956. doi: 10.1182/blood-2021-153190

Sun SX, Olayinka-Amao O, DiBenedetti D. Assessing patient experiences with prophylactic treatments for hemophilia A: concept elicitation for gene therapy. Poster presented at the 62nd Annual Virtual Meeting of the American Society of Hematology (ASH); December 5, 2020. [abstract] Blood. 2020 Nov 5; 136(Suppl 1):33-4.

Spira AI, Chen L, Zhou X, Gnanasakthy A, Wang L, Ungar D, Curiel R, Radford JA, Kahl BS. Symptoms, health-related quality of life, and tolerability of loncastuximab tesirine in patients with relapsed or refractory diffuse large b cell lymphoma. Blood. 2020 Nov 5;136(Suppl 1):3-4. doi: 10.1182/blood-2020-139571

Su J, Kosa K, DiBenedetti D. Patient-reported disease burden: in-depth interviews of patients with CAD. Poster presented at the 2020 Virtual 62nd ASH Annual Meeting and Exposition; December 6, 2020. [abstract] Blood. 2020 Nov 5; 136(Suppl 1):29-30.

Cohen AD, Hari P, Htut M, Berdeja JG, Madduri D, Usmani SZ, Allred AJ, Olyslager Y, Banerjee A, Goldberg JD, Schecter JM, Jackson CC, Gries KS, Fastenau J, Deraedt W, Carrasco MJ, Akram M, Hossain F, Crawford R, Morrison R, Doward L, Jakubowiak A, Jagannath S. Patient expectations and perceptions of treatment in cartitude-1: phase 1b/2 study of ciltacabtagene autoleucel in relapsed/refractory multiple myeloma. Poster presented at the 62nd Annual Virtual Meeting of the American Society of Hematology (ASH); December 2020. [abstract] Blood. 2020 Nov; 136(Suppl 1):13-6. doi: 10.1182/blood-2020-136383

Eze IC, Foraster M, Schaffner E, Vienneau D, Pieren R, Imboden M, Wunderli J, Cajochen C, Brink M, Roosli M, Probst-Hensch N. Incidence of depression in relation to transportation noise exposure and noise annoyance in the SAPALDIA study. Environ Int. 2020 Nov;144:106014. doi: 10.1016/j.envint.2020.106014

Cerletti P, Eze IC, Schaffner E, Foraster M, Viennau D, Cajochen C, Wunderli J, Roosli M, Stolz D, Pons M, Imboden M, Probst-Hensch N. The independent association of source-specific transportation noise exposure, noise annoyance and noise sensitivity with health-related quality of life. Environ Int. 2020 Oct;143:105960. doi: 10.1016/j.envint.2020.105960

Wesselink AK, Hatch EE, Rothman KJ, Willis SK, Orta OR, Wise LA. Pesticide residue intake from fruits and vegetables and fecundability in a North American preconception cohort study. Environ Int. 2020 Jun;139:105693. doi: 10.1016/j.envint.2020.105693

Fossati S, Valvi D, Martinez D, Cirach M, Estarlich M, Fernandez-Somoano A, Guxens M, Iniguez C, Irizar A, Lertxundi A, Nieuwenhuijsen M, Tamayo I, Vioque J, Tardon A, Sunyer J, Vrijheid M. Prenatal air pollution exposure and growth and cardio-metabolic risk in preschoolers. Environ Int. 2020 May;138:105619. doi: 10.1016/j.envint.2020.105619

Kabadi SM, Goyal RK, Nagar SP, Davis KL, Le H, Du XL, Jain P, Wang ML, Romaguera JE, Kaye JA. Overall survival, adverse events, and economic burden in Medicare-insured patients with mantle cell lymphoma receiving cancer-directed therapy. Presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition; December 7, 2019. Orlando, FL. [abstract] Blood. 2019 Nov 13; 134(Supplement_1):63. doi: 10.1182/blood-2019-122841

Allen LF, Aggarwal K, Vredenburg M, Barnett C, Mladsi D, Kim R. Cost-effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Poster presented at the 61st ASH American Society of Hematology Annual Meeting and Exposition; December 8, 2019. San Diego, CA. [abstract] Blood. 2019 Nov 13; 134(Supplement_1):3454. doi: 10.1182/blood-2019-131822

Houghton K, Dimopoulos M, Lin PL, Guillonneau S, Bury S, Attal M, Richardson PG, Delforge M. Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with isatuximab plus pomalidomide and dexamethasone: Icaria-MM study. Poster presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition; December 7, 2019. Orlando, FL. [abstract] Blood. 2019 Nov 13; 134(Supplement_1):1850. doi: 10.1182/blood-2019-128220

Messina AJ, O'Brien QE, Andrianov V, Moss KR, Vidal L, Vidal-Fisher L. Under reporting of Patient Reported Outcomes (PROs) in Myeloproliferative Neoplasm (MPN) clinical trials. Poster presented at the 61st American Society of Hematology (ASH) Annual Meeting; December 7, 2019. Orlando, FL. [abstract] Blood. 2019 Nov 13; 134(Suppl 1):4754. doi: 10.1182/blood-2019-128741

Goyal RK, Nagar SP, Kabadi SM, Davis KL, Le H, Kaye JA. Overall survival, adverse events, and economic burden in Medicare patients with chronic lymphocytic leukemia receiving cancer-directed therapy. Presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition; December 9, 2019. Orlando, FL. [abstract] Blood. 2019 Nov 13; 134(Supplement 1):796. doi: 10.1182/blood-2019-122842

Dawson KL, Price MA, Torney PA, Gonzalez V, Sae-Hau M, Weiss E, Mange B, Mansfield C, Comenencia-Ortiz E, Masaquel A, Ravelo A. Patient-reported disease burden and age: results from a national patient advocacy survey of patients with chronic lymphocytic leukemia, diffuse large-B-cell lymphoma and follicular lymphoma. Poster presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition; December 9, 2019. Orlando, FL. [abstract] Blood. 2019 Nov 13; 134(Supplement_1):4778. doi: 10.1182/blood-2019-123644

Xie J, Yong A, Waweru C, Sorof TA, Goyal RK, Davis KL, Fellows G, Hillmen P. Real-world treatment patterns and adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib in the UK: a preliminary analysis. Poster presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition; December 2019. Orlando, FL. [abstract] Blood. 2019 Nov 13; 134(Supplement_1):5885. doi: 10.1182/blood-2019-123025

Abellan A, Sunyer J, Garcia-Esteban R, Basterrechea M, Duarte-Salles T, Ferrero A, Garcia-Aymerich J, Gascon M, Grimalt JO, Lopez-Espinosa MJ, Zabaleta C, Vrijheid M, Casas M. Prenatal exposure to organochlorine compounds and lung function during childhood. Environ Int. 2019 Oct;131:105049. doi: 10.1016/j.envint.2019.105049

Brink M, Schaffer B, Vienneau D, Foraster M, Pieren R, Eze IC, Cajochen C, Probst-Hensch N, Roosli M, Wunderli J. A survey on exposure-response relationships for road, rail, and aircraft noise annoyance: differences between continuous and intermittent noise. Environ Int. 2019 Apr;125:277-90. doi: 10.1016/j.envint.2019.01.043

Lenters V, Iszatt N, Forns J, Cechova E, Kocan A, Legler J, Leonards P, Stigum H, Eggesbo M. Early-life exposure to persistent organic pollutants (OCPs, PBDEs, PCBs, PFASs) and attention-deficit/hyperactivity disorder: a multi-pollutant analysis of a Norwegian birth cohort. Environ Int. 2019 Apr;125:33-42. doi: 10.1016/j.envint.2019.01.020

Vienneau D, Heritier H, Foraster M, Eze IC, Schaffner E, Thiesse L, Rudzik F, Habermacher M, Kopfli M, Pieren R, Brink M, Cajochen C, Wunderli JM, Probst-Hensch N, Roosli M. Façades, floors and maps - influence of exposure measurement error on the association between transportation noise and myocardial infarction. Environ Int. 2019 Feb;123:399-406. doi: 10.1016/j.envint.2018.12.015

Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Murthy S, Verma A, Shastri A. Risk stratification and transfusion dependence are independent risk factors for cardiovascular disease (CVD) in myelodysplastic syndrome (MDS). Poster presented at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition; November 13, 2019. [abstract] Blood. 2019; 134(Suppl 1):336. doi: 10.1182/blood-2019-123317

Mueller N, Rojas-Rueda D, Khreis H, Cirach M, Mila C, Espinosa A, Foraster M, McEachan RRC, Kelly B, Wright J, Nieuwenhuijsen M. Socioeconomic inequalities in urban and transport planning related exposures and mortality: a health impact assessment study for Bradford, UK. Environ Int. 2018 Dec;121(Pt1):931-41. doi: 10.1016/j.envint.2018.10.017

Foraster M, Eze IC, Vienneau D, Schaffner E, Jeong A, Heritier H, Rudzik F, Thiesse L, Pieren R, Brink M, Cajochen C, Wunderli J, Roosli M, Probst-Hensch N. Long-term exposure to transportation noise and its association with adiposity markers and development of obesity. Environ Int. 2018 Dec;121(Pt1):879-89. doi: 10.1016/j.envint.2018.09.057

Eze IC, Foraster M, Schaffner E, Vienneau D, Heritier H, Pieren R, Thiesse L, Rudzik F, Rothe T, Pons M, Bettschart R, Schindler C, Cajochen C, Wunderli J, Brink M, Roosli M, Probst-Hensch N. Transportation noise exposure, noise annoyance and respiratory health in adults: a repeated-measures study. Environ Int. 2018 Dec;121(Pt1):741-50. doi: 10.1016/j.envint.2018.10.006

Thiesse L, Rudzik F, Spiegel K, Leproult R, Pieren R, Wunderli JM, Foraster M, Heritier H, Eze IC, Meyer M, Vienneau D, Brink M, Probst-Hensch N, Roosli M, Cajochen C. Adverse impact of nocturnal transportation noise on glucose regulation in healthy young adults: effect of different noise scenarios. Environ Int. 2018 Dec;121(Pt1):1011-23. doi: 10.1016/j.envint.2018.05.036

Kabadi S, Goyal RK, Nagar SP, Kaye JA, Davis KL, Mato A. Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States. Poster presented at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition; December 2, 2018. San Diego, CA. [abstract] Blood. 2018 Nov 29; 132(Supplement 1):3557. doi: 10.1182/blood-2018-99-114735

Burte E, Leynaert B, Bono R, Brunekreef B, Bousquet J, Carsin AE, de Hoogh K, Forsberg B, Gormand F, Heinrich J, Just J, Marcon A, Kunzli N, Nieuwenhuijsen M, Pin I, Stempfelet M, Sunyer J, Villani S, Siroux V, Jarvis D, Nadif R, Jacquemin B. Association between air pollution and rhinitis incidence in two European cohorts. Environ Int. 2018 Jun;115:257-66. doi: 10.1016/j.envint.2018.03.021

Cole-Hunter T, de Nazelle A, Donaire-Gonzalez D, Kubesch N, Carrasco-Turigas G, Matt F, Foraster M, Martinez T, Ambros A, Cirach M, Martinez D, Belmonte J, Nieuwenhuijsen M. Estimated effects of air pollution and space-time-activity on cardiopulmonary outcomes in healthy adults: a repeated measures study. Environ Int. 2018 Feb;111:247-59. doi: 10.1016/j.envint.2017.11.024.

Adrianzen Herrera D, Pradhan K, Snyder R, Karanth S, Janakiram M, Mantzaris I, Murthy S, Verma A, Shastri A. Myelodysplastic Syndromes (MDS) are an independent risk factor for an earlier onset of myocardial infarction and increased mortality from Cardiovascular Disease (CVD). Poster presented at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition; November 29, 2018. San Diego, CA. [abstract] Blood. 2018; 132(Suppl 1):3539. doi: 10.1182/blood-2018-99-115613

Karve S, Nagar S, Goyal R, Kaye JA, Mato AR. Adverse events, resource use, and economic burden in patients with mantle cell lymphoma in the United States. Poster presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition; December 10, 2017. Atlanta, GA. [abstract] Blood. 2017 Dec 7; 130(Supplement 1):3442. doi: 10.1182/blood.V130.Suppl_1.3442.3442

Maiese EM, Graham CN, Hawe E, Le Moine JG, Abraham I, Senbetta M. Cost-effectiveness of daratumumab plus bortezomib and dexamethasone versus bortezomib plus dexamethasone for treatment of patients with multiple myeloma who have received at least one prior therapy: an analysis of the Castor Trial. Poster presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition; December 10, 2017. Atlanta, GA. [abstract] Blood. 2017 Dec 7; 130(Supplement 1):3400. doi: 10.1182/blood.V130.Suppl_1.3400.3400

Maiese EM, Graham CN, Hawe E, Le Moine JG, Abraham I, Senbetta M. Cost-effectiveness of daratumumab plus lenalidomide plus dexamethasone versus lenalidomide plus dexamethasone for treatment of patients with multiple myeloma who have received at least one prior therapy: an analysis of the Pollux trial. Poster presented at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition; December 11, 2017. Atlanta, GA. [abstract] Blood. 2017 Dec 7; 130(Supplement 1):4711. doi: 10.1182/blood.V130.Suppl_1.4711.4711